Concomitant intra-aortic balloon pump and veno-arterial extracorporeal membrane oxygenation for postcardiotomy cardiogenic shock

We aimed to compare the outcomes of ECMO with and without IABP for postcardiotomy cardiogenic shock. The study included 103 patients who needed ECMO for postcardiotomy cardiogenic shock. Patients were grouped according to the use of IABP into ECMO without IABP (n = 43) and ECMO with IABP (n = 60). T...

Full description

Saved in:
Bibliographic Details
Published in:International journal of artificial organs 2023-06, Vol.46 (6), p.384-389
Main Authors: Arafat, Amr A, Almedimigh, Abdulmalik A, Algarni, Khaled D, Ismail, Huda H, Pragliola, Claudio, Adam, Adam I, AlBarrak, Mohammed, Osman, Ahmed, Albabtain, Monirah A, Tantawy, Tarek M
Format: Article
Language:English
Subjects:
Aorta
Aortic valve
Complications
Endocarditis
Extracorporeal membrane oxygenation
Heart valves
Ischemia
Oxygenation
Survival
Weaning
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We aimed to compare the outcomes of ECMO with and without IABP for postcardiotomy cardiogenic shock. The study included 103 patients who needed ECMO for postcardiotomy cardiogenic shock. Patients were grouped according to the use of IABP into ECMO without IABP (n = 43) and ECMO with IABP (n = 60). The study endpoints were hospital complications, successful weaning, and survival. Patients with IABP had lower preoperative ejection fraction (p = 0.002). There was no difference in stroke (p = 0.97), limb ischemic (p = 0.32), and duration of ICU stay (p = 0.11) between groups. Successful weaning was non-significantly higher with IABP (36 (60%) vs 19 (44.19%); p = 0.11). Predictors of successful weaning were inversely related to the high pre-ECMO lactate levels (OR: 0.89; p = 0.01), active endocarditis (OR: 0.06; p = 0.02), older age (OR: 0.95; p = 0.02), and aortic valve replacement (OR: 0.26; p = 0.04). There was no difference in survival between groups (p = 0.80). Our study did not support the routine use of IABP during ECMO support.
ISSN:0391-3988
1724-6040
DOI:10.1177/03913988231170890